| 产品编号 |
英文名称 |
CAS号 |
产品规格 |
价格 |
货期 |
| ZMR-44-0433 |
Dichloro(p-cymene)triphenylphosphineruthenium(II) dichloromethane adduct, min. 98% |
[52490-94-5] |
1g |
咨询 |
3-5周 |
| ZMR-15-4311 |
(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP |
[1439556-82-7] |
100mg |
咨询 |
3-5周 |
| ZMR-15-4331 |
(-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Tol-SKP |
[1548897-80-8] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5131 |
(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu |
[912457-08-0] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0105 |
(-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane, 98+% (S,S)-Me-BPE |
[136779-26-5] |
100mg |
咨询 |
1-3天 |
| ZMR-15-8245 |
(((9,10-Dioxo-9,10-dihydroanthracene-2,6-diyl)bis(oxy))bis(propane-3,1-diyl))bis(phosphonic acid), 98%, 2,6-DPPEAQ |
N/A |
1g |
咨询 |
3-5周 |
| ZMR-15-4330 |
(+)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Tol-SKP |
[1429939-32-1] |
100mg |
咨询 |
3-5周 |
| ZMR-15-4320 |
(+)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (R,R,R)-(+)-Xyl-SKP |
[1429939-35-4] |
100mg |
咨询 |
3-5周 |
| ZMR-40-1056 |
(+)-Bis[1-{(1'R,2'R,5'R)-2'-i-propyl-5'-methylcyclohexyl}indenyl]zirconium(IV) dichloride |
[148347-90-4] |
100mg |
咨询 |
约4周 |
| ZMR-26-1315 |
(R)-(+)-1-[(R)-2-(2'-Diphenylphosphinophenyl)ferrocenyl]ethyldiphenylphosphine, min. 97% |
[565184-32-9] |
10g |
咨询 |
3-5周 |
| ZMR-15-0156 |
(R)-(+)-2,2'-Bis(di-p-tolylphosphino)-6,6'-dimethoxy-1,1'-biphenyl, min. 97% |
[133545-24-1] |
10g |
咨询 |
3-5周 |
| ZMR-15-4310 |
(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP |
[1360823-43-3] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0101 |
(+)-1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane, 98+% (R,R)-Et-BPE |
[136705-62-9] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0104 |
(+)-1,2-Bis((2R,5R)-2,5-dimethylphospholano)ethane, 98+% (R,R)-Me-BPE |
[129648-07-3] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0098 |
(+)-1,2-Bis((2S,5S)-2,5-diethylphospholano)benzene, 98+% (S,S)-Et-DUPHOS |
[136779-28-7] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0092 |
(+)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)benzene, min. 98% (S,S)-Me-DUPHOS |
[136735-95-0] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0474 |
(+)-1,2-Bis((2S,5S)-2,5-diphenylphospholano)ethane, min. 98% (S,S)-Ph-BPE |
[824395-67-7] |
100mg |
咨询 |
1-3天 |
| ZMR-26-1555 |
(R)-(+)-1-[(R)-2-(2'-Di-3,5-xylylphosphinophenyl)ferrocenyl]ethyldi-3,5-xylylphosphine, min. 97% |
[894771-28-9] |
10g |
咨询 |
3-5周 |
| ZMR-15-0178 |
(R)-(+)-2,2'-Bis(diphenylphosphino)-6,6'-dimethoxy-1,1'-biphenyl, min. 97% (R)-MeO-BIPHEP |
[133545-16-1] |
10g |
咨询 |
3-5周 |
| ZMR-07-7043 |
2,2-Bis[(4R)-4-benzyl-2-oxazolin-2-yl]propane, 98%, (99% ee) |
[141362-77-8] |
100mg |
咨询 |
3-5周 |
| ZMR-07-0306 |
(+)-2,6-Bis[(4R)-4-(i-propyl)-2-oxazolin-2-yl]pyridine, 98+% (R)-(i-Pr)-pybox |
[131864-67-0] |
1g |
咨询 |
3-5周 |
| ZMR-07-0303 |
(+)-2,6-Bis[(4R)-4-phenyl-2-oxazolin-2-yl]pyridine, 98+% (R,R)-Ph-pybox |
[128249-70-7] |
2g |
咨询 |
3-5周 |
| ZMR-07-0307 |
(-)-2,6-Bis[(4S)-4-(i-propyl)-2-oxazolin-2-yl]pyridine, 98+% (S)-(i-Pr)-pybox |
[118949-61-4] |
1g |
咨询 |
3-5周 |
| ZMR-15-1821 |
(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-(1-methylethyl)-4,5-dihydrooxazole, 98% (R)-iPr-PHOX |
[164858-78-0] |
1g |
咨询 |
3-5周 |
| ZMR-15-1455 |
(+)-6,6'-{[(1R,3R)-1,3-Dimethyl-1,3-propanediyl]bis(oxy)}bis[4,8-bis(t-butyl)-2,10-dimethoxy-bibenzo[d,f][1,3,2]dioxaphosphepin], min. 95% (R,R)-Chiraphite |
[149646-83-3] |
100mg |
咨询 |
1-3天 |
| ZMR-08-0620 |
(R)-(+)-6,6'-Dibromo-2,2'-bis(methoxymethoxy)-1,1'-binaphthyl, min. 98% |
[179866-74-1] |
1g |
咨询 |
3-5周 |
| ZMR-26-0956 |
(R)-(+)-[(R)-2-Dicyclohexylphosphinoferrocenyl](N,N-dimethylamino)(2-dicyclohexylphosphinophenyl)methane, min. 97% |
[1156547-61-3] |
10g |
咨询 |
3-5周 |
| ZMR-07-0341 |
(+)-N,N'-(1S,2S)-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide), min. 98% (S,S)-DACH-Pyridyl Trost Ligand |
[172138-95-3] |
1g |
咨询 |
3-5周 |
| ZMR-08-2045 |
racemic-5,5',6,6'-Tetramethyl-3,3'-di-t-butyl-1,1'-biphenyl-2,2'-diol, 99% rac-BIPHEN H2 |
[101203-31-0] |
25g |
咨询 |
3-5周 |
| ZMR-26-0960 |
(R)-(-)-1-{(S)-2-[Bis(3,5-di-trifluoromethylphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine, min. 97% |
[292638-88-1] |
10g |
咨询 |
3-5周 |
| ZMR-26-1150 |
(R)-(-)-1-{(S)-2-[Bis(3,5-dimethyl-4-methoxyphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine, min. 97% |
[360048-63-1] |
10g |
咨询 |
3-5周 |
| ZMR-15-1232 |
(R)-(-)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine, min. 97% (R)-MONOPHOS |
[157488-65-8] |
1g |
咨询 |
3-5周 |
| ZMR-08-0160 |
(R)-(-)-1,1'-Bi-2-naphthol bis(trifluoromethanesulfonate), 98% |
[126613-06-7] |
1g |
咨询 |
3-5周 |
| ZMR-15-4321 |
(-)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 97% (S,S,S)-(-)-Xyl-SKP |
[1429939-31-0] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0097 |
(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene, 98+% (R,R)-Et-DUPHOS |
[136705-64-1] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0096 |
(-)-1,2-Bis((2R,5R)-2,5-dimethylphospholano)benzene, min.98% (R,R)-Me-DUPHOS |
[147253-67-6] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0473 |
(-)-1,2-Bis((2R,5R)-2,5-diphenylphospholano)ethane, min. 95% (R,R)-Ph-BPE |
[528565-79-9] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0102 |
(-)-1,2-Bis((2S,5S)-2,5-diethylphospholano)ethane, 98+% (S,S)-Et-BPE |
[136779-27-6] |
100mg |
咨询 |
1-3天 |
| ZMR-15-0411 |
(-)-1,2-Bis((2S,5S)-2,5-di-i-propylphospholano)benzene, 98+% (S,S)-i-Pr-DUPHOS |
[147253-69-8] |
100mg |
咨询 |
3-5周 |
| ZMR-06-1040 |
(4S,5S)-(+)-O-Isopropylidene-2,3-dihydroxy-1,4-bis(p-tosyl)butane |
[37002-45-2] |
1g |
咨询 |
3-5周 |
| ZMR-15-1269 |
(-)-4,6-Bis((S)-(2-methoxyphenyl)(phenyl)phosphinyl)dibenzo[b,d]furan, min. 97% |
[2119686-75-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1456 |
(-)-6,6'-{[(1S,3S)-1,3-Dimethyl-1,3-propanediyl]bis(oxy)}bis[4,8-bis(t-butyl)-2,10-dimethoxy-bibenzo[d,f][1,3,2]dioxaphosphepin], min. 95% (S,S)-Chiraphite |
[852042-07-0] |
100mg |
咨询 |
3-5周 |
| ZMR-07-0340 |
(-)-N,N'-(1R,2R)-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide), min. 98% (R,R)-DACH-Pyridyl Trost Ligand |
[218290-24-5] |
1g |
咨询 |
3-5周 |
| ZPC-DI008n6 |
(-S-C11-EG6-OCH2-COONHS)2 |
N/A |
50 mg |
咨询 |
6周 |
| ZMR-07-0488 |
(1'R,2'R,3aS,3"aS,8aR,8"aR)-(+)-3,3",3a,3"a,8,8",8a,8"a-Octahydrodispiro{2H-indeno[1,2-d]oxazole-2,1'-cyclohexane-2',2"-[2H]indeno[1,2-d]oxazole} WOLF BISOXAZOLIDINE |
[947515-50-6] |
1g |
咨询 |
3-5周 |
| ZMR-27-0554 |
Dichloro[1,1'-bis(diphenylphosphino)ferrocene]cobalt(II), 99% |
[67292-36-8] |
1g |
咨询 |
3-5周 |
| ZMR-29-6000 |
(1,10-Phenanthroline)bis(triphenylphosphine)copper(I) nitrate dichloromethane adduct, 98% |
[33989-10-5] |
25g |
咨询 |
3-5周 |
| ZMR-29-3100 |
Bis(triphenylphosphine)copper(I) nitrate, 99% |
[106678-35-7] |
25g |
咨询 |
3-5周 |
| ZMR-44-0759 |
(1,3-Bis(2,6-diisopropylphenyl)-4-((4-ethyl-4-methylpiperzain-1-ium-1-yl)methyl)imidazolidin-2-ylidene)(2-isopropoxybenzylidene)ruthenium(II)dichloride chloride dihydrate FixCat |
[1799947-97-9] |
100mg |
咨询 |
3-5周 |
| ZMR-28-0040 |
(1,5-Cyclooctadiene)(duroquinone) nickel(0), min. 98% |
[40759-64-6] |
1g |
咨询 |
3-5周 |
